Diabetes Management Devices Market

Diabetes management devices include insulin delivery systems and blood glucose monitoring devices, which are used to treat diabetes effectively and efficiently with fewer side effects. Diabetes (type 1 and type 2) is a chronic disease condition, which occurs due to glucose impairment. The major factors contributing to the disease include obesity, urbanization, sedentary lifestyle, smoking, an elevated level of cholesterols, and hypertension. Vendors in this market are offering high-end insulin delivery systems (less invasive, sleek, pocket-sized, and portable devices) and continuous glucose monitoring systems, which are highly efficient and have user-friendly features.
Diabetes Management Devices Market contains market size and forecasts of Diabetes Management Devices in Global, including the following market information:
Global Diabetes Management Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Diabetes Management Devices market was valued at 41190 million in 2021 and is projected to reach US$ 64850 million by 2028, at a CAGR of 6.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Blood Glucose Monitoring Device Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Diabetes Management Devices include Abbott Laboratories, Dexcom, Roche, Lifescan, Medtronic, Terumo, B. Braun Melsungen, BD and Ascensia (Bayer), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Diabetes Management Devices companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetes Management Devices Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Diabetes Management Devices Market Segment Percentages, by Type, 2021 (%)
Blood Glucose Monitoring Device
Insulin Delivery Systems
Global Diabetes Management Devices Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Diabetes Management Devices Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Diabetes Management Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Diabetes Management Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diabetes Management Devices revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Diabetes Management Devices revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Dexcom
Roche
Lifescan
Medtronic
Terumo
B. Braun Melsungen
BD
Ascensia (Bayer)
Senseonics Holdings
Johnson & Johnson
Eli Lilly
Novo Nordisk
Sanofi
Ypsomed Holding
GlySens Incorporated
Meiqi Medical Equipment
San Meditech
All Medicus